Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Christina Lake CannabisXCNQ:CLC Gross Margin % is 28.46% as of May. 2026, which is 7% below its 10-year median of 30.62. The stock has 4 warning signs investors should review. Among 942 Drug Manufacturers companies, Christina Lake Cannabis ranks worse than 82.59% on this metric.
Christina Lake Cannabis (XCNQ:CLC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Christina Lake Cannabis had a gross margin of 28.46% for the quarter that ended in May. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Christina Lake Cannabis Gross Margin % Related Terms
Christina Lake Cannabis Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Christina Lake Cannabis Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Christina Lake Cannabis's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Christina Lake Cannabis (XCNQ:CLC) has a Gross Margin % of 28.46% as of May. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Christina Lake Cannabis and its competitors. This is near median its historical median of 30.62. Over the past decade, Christina Lake Cannabis' Gross Margin % has ranged from 1.57 to 68.41. According to the industry distribution chart, Christina Lake Cannabis ranks #778 out of 942 companies in the Drug Manufacturers industry, placing it in the top 82.6%.
Is Christina Lake Cannabis' Gross Margin % too high?
Christina Lake Cannabis' current Gross Margin % of 28.46% is near median its 10-year median of 30.62. Over the past 10 years, this metric has ranged from a low of 1.57 to a high of 68.41. The Drug Manufacturers industry median Gross Margin % is 48.50. Christina Lake Cannabis' value of 28.46% is 41.3% below this industry median. Based on the distribution chart, Christina Lake Cannabis ranks #778 out of 942 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Christina Lake Cannabis' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #778 out of 942 companies for Gross Margin %. This places Christina Lake Cannabis in the lower half of its industry. The industry median Gross Margin % is 48.50. Christina Lake Cannabis' value of 28.46% is 41.3% below this benchmark. Historically, Christina Lake Cannabis' own Gross Margin % has ranged from 1.57 to 68.41 over the past decade. While the company's 10-year median is 30.62 vs. the industry median of 48.50, Christina Lake Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.50, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Christina Lake Cannabis's current Gross Margin % of 28.46% is 41.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Christina Lake Cannabis and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current Gross Margin % is 28.46%, which is near median its own 10-year median of 30.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (XCNQ:CLC) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.02, compared to a current price of C$0.03 — trading 25% above its estimated fair value. The current Gross Margin % is 28.46%, which is near median its 10-year median of 30.62 and 41.3% below the Drug Manufacturers industry median of 48.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Christina Lake Cannabis (XCNQ:CLC), the current Gross Margin % is 28.46% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:CLC has been successfully added to your 
